Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • Support GPB Today
  • Podcast: Manufacturing Danger: The BioLab Story
  • TV Highlights This Week

News Articles: drug prices

President Trump, joined by National Institutes of Health Director Jay Bhattacharya and Health and Human Services Secretary Robert F. Kennedy Jr., talks about an executive order aimed at reducing the cost of prescription drugs.

Tagged as: 

  • Health

Trump signs an order to reduce drug prices, but it's unclear how it would work

President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.

May 12, 2025
|
By:
  • Sydney Lupkin
Medicare negotiations on drug prices can happen sooner for pills than many drugs that are injected.

Tagged as: 

  • Health

Trump signs executive action to lower drug prices

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.

April 17, 2025
|
By:
  • Sydney Lupkin
The federal government has the power to negotiate the prices Medicare pays for some drugs.

Tagged as: 

  • Health

Medicare targets 15 more drugs for price negotiations -- including Ozempic

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare. 

January 17, 2025
|
By:
  • Sydney Lupkin
Prescription drugs prices rose this year for many drugs, though the hikes were not as steep on average as some past years.

Tagged as: 

  • Health

Drugmakers hiked prices for hundreds of drugs in early January

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including Ozempic, drugs for HIV, cancer and many others.

January 14, 2025
|
By:
  • Sydney Lupkin
The first price negotiations between Medicare and drugmakers could save the billions of dollars a year for taxpayers and beneficiaries.

Tagged as: 

  • Health

Medicare negotiated drug prices for the first time. Here’s what it got

The White House announced new Medicare drug prices for 10 medicines popular with beneficiaries. It's the first time the federal program has negotiated lower prices with the pharmaceutical industry.

August 15, 2024
|
By:
  • Sydney Lupkin and
  • Asma Khalid
GPB News NPR

Tagged as: 

  • Health

Medicare negotiations for lower drug prices near the finish line

Medicare's new authority to negotiate lower prescription drug prices represents a signature accomplishment of the Biden-Harris administration. Here's what to know as the first set of talks wraps up.

July 30, 2024
|
By:
  • Sydney Lupkin
Mark Cuban's Cost Plus Drugs online pharmacy is adding the oral contraceptive Yaz from Bayer to its list of discounted medicines.

Tagged as: 

  • Health

Bayer makes a deal on popular contraceptive with Mark Cuban's online pharmacy

Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara.

February 19, 2024
|
By:
  • Sydney Lupkin
Vermont Sen. Bernie Sanders, chairman of the Senate Health, Education, Labor, and Pensions Committee, pressed executives from Bristol Myers Squibb, Merck and Johnson & Johnson about the prices they charge for drugs in the U.S.

Tagged as: 

  • Health

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

February 08, 2024
|
By:
  • Sydney Lupkin
Drug price hikes appear to be moderate this year, with some drug prices falling.

Tagged as: 

  • Health

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

January 18, 2024
|
By:
  • Sydney Lupkin
Activists protest the prices of prescription drug outside the Department of Health and Human Services in Washington, D.C., in October 2022.

Tagged as: 

  • Health

White House proposes to 'march in' on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

December 07, 2023
|
By:
  • Sydney Lupkin
Chairman of the Senate Health, Education, Labor and Pensions Committee Sen. Bernie Sanders, a Vermont Independent, questions Dr. Monica Bertagnolli during her confirmation hearing to become director of the National Institutes of Health.

Tagged as: 

  • Health

Sen. Sanders pushes NIH to rein in drug prices

The National Institutes of Health has been reluctant to use its leverage as a biomedical research funder to influence drug pricing. Sen. Bernie Sanders is pressing NIH's new director to take action.

November 17, 2023
|
By:
  • Sydney Lupkin
President Joe Biden and Vice President Kamala Harris at the White House event on August 29 where they announced the list of the first 10 medicines targeted for Medicare negotiations.

Tagged as: 

  • Health Care

All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

October 04, 2023
|
By:
  • Sydney Lupkin

Tagged as: 

  • Health Care

What's a fair price for a prescription drug? Medicare's about to weigh in

Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.

July 28, 2023
|
By:
  • Leslie Walker and
  • Dan Gorenstein
Pharmacy benefit managers are middlemen who work with drug companies and insurers, helping set the retail prices for prescription drugs Americans rely on for their health. They're now the subject of a number of new bills in Congress.

Tagged as: 

  • Health

What to know about the drug price fight in those TV ads

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

July 07, 2023
|
By:
  • Arthur Allen
This April 24, 2008, file photo shows the former North American headquarters of Novo Nordisk Inc., in Plainsboro, N.J. The Danish drugmaker will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.

Tagged as: 

  • Health

Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year

The Danish drugmaker's move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.

March 14, 2023
|
By:
  • The Associated Press
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®